Posts by: Jose Marques Lopes, PhD

A new literature review updated the information on the effectiveness and safety of different classes of treatment strategies for rheumatoid arthritis (RA). The study, “Efficacy of glucocorticoids, conventional and ... Read more

March 22, 2017March 22, 2017

Low RA Disease Activity Seen for 3 Years After Humira Stopped in Many Patients, Trial Shows

News, rheumatoid arthritis

Results from a clinical trial revealed that patients with early rheumatoid arthritis (RA) who stopped taking Humira (adalimumab) once their RA was under control maintained a low disease activity for up to ... Read more

March 15, 2017March 15, 2017

Namilumab Therapy Successful in Phase 1b Trial of Rheumatoid Arthritis

News, rheumatoid arthritis

Namilumab, an investigational monoclonal antibody that binds with high affinity to GM-CSF, shows promise in the treatment of rheumatoid arthritis (RA), new research shows. GM-CSF stands for “granulocyte macrophage ... Read more

March 13, 2017March 13, 2017

Cases of RA-associated Pulmonary Hypertension Show Need for Timely Diagnosis

News, rheumatoid arthritis

A timely diagnosis and effective treatment strategy for patients with pulmonary hypertension (PH) associated with rheumatoid arthritis (RA) can prevent right heart failure and significantly enhance their quality of ... Read more

Posts by: Jose Marques Lopes, PhD

Jose Marques Lopes, PhD

Review Updates Different Treatment Strategies for Rheumatoid Arthritis

Low RA Disease Activity Seen for 3 Years After Humira Stopped in Many Patients, Trial Shows

Namilumab Therapy Successful in Phase 1b Trial of Rheumatoid Arthritis

Cases of RA-associated Pulmonary Hypertension Show Need for Timely Diagnosis

Pin It on Pinterest